Diagnostic and prognostic value of ROR1 antigen in patients with chronic lymphocytic leukemia
10.3760/cma.j.cn114452-20211201-00747
- VernacularTitle:受体酪氨酸激酶样孤儿受体1在慢性淋巴细胞白血病中的诊断价值及预后意义
- Author:
Fen WU
1
;
Xiao CHEN
;
Sishu ZHAO
;
Lu LIU
;
Jiahua DING
;
Yujie WU
Author Information
1. 东南大学附属中大医院血液科，南京 210009
- Keywords:
Leukemia, lymphocytic, chronic, B-Cell;
Lymphoma;
Receptor tyrosine kinase-like orphan receptors;
Diagnosis;
Karyotype;
Flow cytometry
- From:
Chinese Journal of Laboratory Medicine
2022;45(5):502-508
- CountryChina
- Language:Chinese
-
Abstract:
Objective:To detect the expression of receptor tyrosine kinase-like orphan receptor 1 (ROR1) antigen in chronic lymphocytic leukemia (CLL) and evaluate its diagnostic value and explore its correlation with the abnormalities of genetics and molecular biology.Methods:All of 209 newly diagnosed B-cell chronic lymphoproliferative disorders (B-CLPD) patients who were admitted to the First Affiliated Hospital of Nanjing Medical University (Jiangsu Provincial People′s Hospital) from November 2020 to November 2021 were collected retrospectively, including 70 cases of CLL with typical phenotype, 16 cases of CLL with atypical phenotype, 14 cases of MCL, and 109 cases of other types of B-CLPD. Multi-parameter flow cytometry (FCM) was used to detect the expression levels of ROR1 in tumor cells of 209 patients. And then the diagnostic value of ROR1 in CLL patients and its correlation with the genetic and molecular biological abnormalities were analyzed by c2 test and fourfold table assessment.Results:The positive expression rate of ROR1 in CLL patients was significantly higher than that in non-CLL patients (78%>11%, P<0.001); there was no significant difference of ROR1 expression between typical phenotype CLL and atypical phenotype CLL (81%>63%, P>0.05). The positive expression rate of ROR1 in atypical phenotype CLL was significantly higher than that in MCL (63%>21%, P<0.05). Additionally, there was significant difference in detection rate of chromosomal abnormalities between ROR1 +CLL group and ROR1 -CLL group. The detection rate of complex karyotype in ROR1 +CLL group was higher than that in ROR1 -CLL group (34%>14%, P<0.05). The CLL patients over 60 years old had higher ROR1 positive rate ( P<0.05). Conclusions:ROR1 can be helpful in the diagnosis of CLL, especially in the differential diagnosis of atypical phenotype CLL, MCL and other types of B-CLPD. Patients with ROR1 positive expression were older and more likely to detect complex chromosomal karyotypes.
